Spanish Red Biotech Pipeline

MSD

Pembrolizumab

Type: Biodrugs/ Drugs
Therapeutic area: Cancer
Indication: Pembrolizumab via Subcutaneous Injection of MK-3475A, a Formulation of Pembrolizumab With MK-5180, in Participants with Advanced Solid Tumors.
Phase: 1Phase I in Spain